- You can now get updates from the Hepatitis C Harm Reduction Project emailed to you every week, letting you know what new posts and materials have been added to the site. To subscribe, click on the link on the left side of the page or email us.
- We want your feedback! At the end of every post on the weblog is a link for 'Comments' -- that's where you can offer your opinions, information, personal experience, and questions, for everyone to see. We'd love to see more dialogue on this site. If you have general feedback, or want to respond privately, you can also email us.
- Watch for a couple of follow-up posts in the next week or so -- including an update on hepatitis C protease inhibitor research, talking about lessons learned from BILN 2061 and the status of Schering-Plough's compound and VX-950 from Vertex. Also, part 3 of 'When Treatment Doesn't Work' focusing on potential differences between the pegylated interferons.
- We've been writing a lot about hepatitis C treatment lately. We'll continue to cover treatment, but look for more in the next few weeks about prevention and education, drug use, access to medical care, etc. And let us know what you want to hear about.
Thanks for visiting the site -- pass the link on and spread the word.